Group 1 - The company has not yet ventured into the specialty engineering plastics sector [1] - The core business of the company focuses on the recycled plastics field, emphasizing an innovative model of "recycling - regeneration - utilization" [1] - The company aims to achieve efficient recycling and maximization of value from recycled plastic resources through technological and model innovation, promoting green and sustainable development in the industry [1]

（文章来源：证券日报） 证券日报网讯英科再生9月9日在互动平台回答投资者提问时表示，截至目前，公司暂未布局塑料裂解相 关技术及项目。公司核心业务聚焦于再生塑料领域，以"回收-再生-利用"全产业链创新模式为核心方 向，致力于通过技术与模式创新，实现再生塑料资源的高效循环与价值最大化利用，推动行业绿色可持 续发展。后续若有业务重大调整，公司将严格按照相关规定及时履行信息披露义务。 ...

（文章来源：证券日报） 证券日报网讯英科再生9月9日在互动平台回答投资者提问时表示，为进一步优化公司全球业务战略布 局，强化供应链体系韧性建设，提升对全球市场动态的响应效率与核心竞争力，公司自2018年-2019年 起已前瞻性启动海外生产基地投资布局，重点落地马来西亚、越南两大核心制造基地，为全球化运营奠 定坚实基础。后续，公司将持续聚焦海外基地的精细化运营管理，稳步推进产能释放与效能提升，以更 优质的供应链保障与更高效的市场服务，助力公司长期战略目标实现。 ...

格隆汇9月9日丨英科再生(688087.SH)在互动平台表示，截至目前，公司暂未布局塑料裂解相关技术及 项目。公司核心业务聚焦于再生塑料领域，以 "回收 - 再生 - 利用" 全产业链创新模式为核心方向，致 力于通过技术与模式创新，实现再生塑料资源的高效循环与价值最大化利用，推动行业绿色可持续发 展。后续若有业务重大调整，公司将严格按照相关规定及时履行信息披露义务。 ...

格隆汇9月9日丨英科再生(688087.SH)在互动平台表示，截至目前，公司暂未布局塑料裂解相关技术及 项目。公司核心业务聚焦于再生塑料领域，以 "回收 - 再生 - 利用" 全产业链创新模式为核心方向，致 力于通过技术与模式创新，实现再生塑料资源的高效循环与价值最大化利用，推动行业绿色可持续发 展。后续若有业务重大调整，公司将严格按照相关规定及时履行信息披露义务。 ...

Investment Rating - The report maintains a "Buy" rating for the company [1] Core Views - The company achieved a revenue of 1.666 billion yuan in H1 2025, representing a year-on-year increase of 16.13%. The net profit attributable to shareholders was 146 million yuan, a decrease of 6.01% year-on-year, primarily due to foreign exchange losses from the appreciation of the RMB against the USD. Excluding this factor, the company's operational profitability, revenue, and net profit all showed positive growth [7] - The revenue from the decoration and building materials segment grew by 38% year-on-year, accounting for 37.27% of total revenue in H1 2025. The company’s product mix, including high-value home consumer goods, contributed to over 75% of total revenue [7] - The company plans to distribute a cash dividend of 0.1 yuan per share, totaling 19 million yuan, reflecting its commitment to shareholder returns [7] - The company has a global marketing presence, with overseas revenue accounting for 88.80% of total revenue in H1 2025, showing a year-on-year increase of 27.84% [7] Financial Summary - The company forecasts total revenue of 2.924 billion yuan for 2024, with a year-on-year growth rate of 19.09%. The net profit attributable to shareholders is projected to be 307 million yuan, reflecting a significant increase of 57.07% compared to 2023 [1][8] - The earnings per share (EPS) is expected to be 1.58 yuan in 2024, increasing to 2.42 yuan by 2027, with a corresponding price-to-earnings (P/E) ratio decreasing from 16.86 in 2024 to 11.02 in 2027 [1][8] - The company’s operating cash flow for H1 2025 was 245 million yuan, an increase of 17.50% year-on-year, indicating improved operational efficiency [7]

（文章来源：证券日报） 证券日报网讯 9月1日晚间，英科再生发布公告称，截至2025年8月31日，公司通过上海证券交易所交易 系统以集中竞价交易方式回购公司股份848，200股，占公司总股本的0.44%。 ...

证券代码：688087 证券简称：英科再生 公告编号：2025-051 英科再生资源股份有限公司 关于以集中竞价方式回购股份的进展公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 公司 2024 年度权益分派实施后,公司以集中竞价交易方式回购股份价格上限由 不超过人民币 41.44 元/股（含）调整为不超过人民币 41.38 元/股（含）。具体情况 详见公司披露于上海证券交易所网站（www.sse.com.cn）的《英科再生资源股份有 限公司关于 2024 年年度权益分派实施后调整回购股份价格上限的公告》（公告编 号：2025-036）。 二、回购股份的进展情况 根据《上市公司股份回购规则》《上海证券交易所上市公司自律监管指引第 7 号——回购股份》的相关规定，公司在回购期间，应当在每个月的前 3 个交易日 内公告截至上月末的回购进展情况。现将公司回购股份进展情况公告如下： | 回购方案首次披露日 | 2025/4/8 | | | | | --- | --- | --- | --- | --- | | 回购 ...

格隆汇9月1日丨英科再生(688087.SH)公布，截至2025年8月31日，公司通过上海证券交易所交易系统以 集中竞价交易方式回购公司股份848,200股，占公司总股本的0.44%，回购成交的最高价为28.48元/股， 最低价为25.43元/股，支付的资金总额为人民币23,011,177.05元（不含交易费用）。 ...

Group 1: Company Highlights - Mindray Medical launched the world's first clinically implemented critical care AI model and established an animal healthcare subsidiary [1] - Jieshun Technology's cloud-managed SaaS service increased to 16,600 lanes, with software and cloud service revenue reaching 125 million yuan, a year-on-year growth of 26.11% [1] - State Grid Information Technology reported a revenue of 3.525 billion yuan, a decrease of 4.55% year-on-year, while its virtual power plant business is being applied in multiple cities [2] - Inke Recycling focuses on high-value applications of recycled plastics, with significant growth in non-European markets and a projected dividend of 1.00 yuan per 10 shares [3] - ZaiJing Pharmaceutical achieved a revenue of 376 million yuan, a 56% increase, driven by sales growth of its drugs [4] - Tianzhihang reported a revenue of approximately 125 million yuan, a year-on-year increase of 114.89%, with significant growth in orthopedic surgical robot sales [5] - Aibo Medical's revenue reached 787 million yuan, a 14.72% increase, with a gross margin of 65.25% [6] - Mankalon's strategy focuses on expanding its presence in core urban areas and enhancing profitability of franchise stores [7] - Oulu Tong's revenue reached 2.12 billion yuan, a 32.59% increase, with data center power business revenue growing by 94.30% [8] - Sun Paper's special paper project is operational, with plans for further production capacity expansion [9] - Taili Technology is enhancing its market penetration and focusing on customized material solutions for various industries [10] Group 2: Financial Performance - Jieshun Technology's parking asset operation revenue grew by 49.86%, with new orders totaling 677 million yuan [1] - State Grid Information Technology's net profit decreased by 11.01% due to increased corporate income tax [2] - Inke Recycling's non-U.S. market revenue grew by 31.15% year-on-year [3] - ZaiJing Pharmaceutical's new drug approvals are expected to boost future sales [4] - Tianzhihang's orthopedic robot surgeries exceeded 22,000 cases, indicating strong market demand [5] - Aibo Medical's second-quarter revenue was 430 million yuan, a 14.44% increase year-on-year [6] - Oulu Tong's R&D expenses increased by 28.26%, reflecting investment in innovation [8] - Sun Paper's projects are expected to enhance its competitive position in the market [9]